Status:
COMPLETED
Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study
Lead Sponsor:
Weprom
Collaborating Sponsors:
Kelindi
Conditions:
Child Development Disorder
Post Partum Depression
Eligibility:
All Genders
Up to 3 years
Brief Summary
After birth, the mother-child dyad can be impacted by issues which are usually under-detected or detected at early stage. Among these issues, neurodevelopmental disorders (NDD) such as autism spectrum...
Eligibility Criteria
Inclusion
- Parent of child or more under 3 years of age
- User of application Malo
Exclusion
- Parent of a child who has already been diagnosed with a developmental disorder, known physical or mental disability
Key Trial Info
Start Date :
November 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 7 2022
Estimated Enrollment :
4346 Patients enrolled
Trial Details
Trial ID
NCT05215028
Start Date
November 11 2021
End Date
January 7 2022
Last Update
January 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ILC
Le Mans, France, 72000